U.S. Online Retail and Ecommerce Stock News

If you are wondering whether Merchants Bancorp at around US$42.27 is still offering value or edging toward the expensive side, you are not alone. The stock has returned 2.6% over the last week, 27.4% year to date and 15.4% over the past year, with a 2.4% decline across the last 30 days adding a bit of extra uncertainty for anyone thinking about entry points. Recent attention around Merchants Bancorp has centered on its position in the diversified financials space and how investors are...

Event context and recent performance Saul Centers (BFS) has attracted fresh attention after recent share price moves. The stock closed at $32.34, with a 1-day return of a 1% decline, a flat performance over the week, and a 5.8% decline over the past month. See our latest analysis for Saul Centers. That recent 5.8% one month share price decline sits against a modest 2.5% 90 day share price return and a 2.5% year to date share price gain. The 1 year total shareholder return is slightly...

What recent performance says about Tapestry (TPR) Tapestry (TPR) has seen its share price slip about 1.8% over the past day and roughly 1.4% over the past week, while the stock is down around 11.5% over the past month. Despite these shorter term declines, Tapestry shows a positive return of about 5.7% over the past 3 months and 7.6% year to date, with a 1 year total return near 100.5%. See our latest analysis for Tapestry. Recent trading has cooled after a strong run, with the latest share...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Steel...

Why ArriVent BioPharma (AVBP) is on investors’ radar ArriVent BioPharma (AVBP) has drawn attention after recent trading, with the stock last closing at US$21.43 and showing mixed short term performance across the past week, month, and past 3 months. See our latest analysis for ArriVent BioPharma. At the current share price of US$21.43, ArriVent BioPharma’s recent 30 day share price return of a 7.99% decline contrasts with a 3.03% year to date share price gain and a 13.09% total shareholder...

Recent commentary on Ellington Financial (EFC) focuses on how its hedging, diversified portfolio, financing sources, and relatively low leverage are helping it manage mortgage market volatility and ongoing loan origination activity. See our latest analysis for Ellington Financial. At a share price of US$11.55, Ellington Financial has seen a 2.21% 7 day share price gain, but its 30 day and year to date share price returns of 7.75% and 15.57% declines suggest momentum has cooled, even as the 3...

Microsoft (MSFT) is experiencing its sharpest correction in years after ramping up AI infrastructure spending and pausing hiring in key cloud and sales units, even as its cloud and AI businesses continue to perform strongly. See our latest analysis for Microsoft. Microsoft’s share price has fallen 24.6% year to date and about 26.9% over three months, with a 10.9% 30 day share price decline. Recent AI capex headlines and hiring pauses have reinforced a sense that momentum is fading, despite...

AnaptysBio (ANAB) has drawn attention after its recent share performance, with the stock showing negative returns over the past week, alongside positive moves over the past month and past 3 months. See our latest analysis for AnaptysBio. At a share price of $57.40, AnaptysBio has seen a sharp 11.68% one day share price decline and a 7.96% 7 day share price pullback. However, its 27.70% year to date share price return and 1 year total shareholder return of 202.90% indicate that longer term...

Why WeRide Stock Is on Investor Radars Now WeRide (WRD) has drawn fresh attention after recent trading moves, with the share price closing at US$6.96 and short term returns swinging between gains over the past week and declines over the month and past 3 months. See our latest analysis for WeRide. Recent trading has been choppy, with a 1 day share price return of 9% decline, a 7 day share price return of 9.53% gain, and a year to date share price return of 25.93% decline, while the 1 year...

Western Digital (WDC) came under pressure after Google introduced its TurboQuant compression algorithm, a tool designed to cut memory usage for large AI models and prompting investors to reassess demand for memory hardware. See our latest analysis for Western Digital. The recent pullback around Google’s TurboQuant news comes after a strong run, with Western Digital’s 90 day share price return of 51.67% and a very large 1 year total shareholder return. Shorter term momentum looks choppy, while...

Federal court certifies a class-action lawsuit against NasdaqGS:NVDA over alleged misrepresentation of gaming GPU revenue tied to cryptocurrency mining in 2017 to 2018. The certified class covers investors who bought Nvidia stock between August 2017 and November 2018. The case moves closer to trial after the Supreme Court declined to hear Nvidia’s appeal, following earlier SEC enforcement action related to similar disclosures. Nvidia, traded as NasdaqGS:NVDA, is best known for graphics...

Republic Services (RSG) is back in focus after recent commentary highlighted a slowdown in demand, with annualized revenue growth of 5.3% over the past two years trailing its five year trend. See our latest analysis for Republic Services. Recent trading reflects that cooling demand story, with a 30 day share price return of a 2.6% decline and a 1 year total shareholder return of an 8.6% decline. This contrasts with a much stronger 5 year total shareholder return of 130.1% and suggests that...

Stock performance snapshot and recent context United Community Banks (UCB) stock has seen mixed recent performance, with a 1 day return of about a 1.3% decline, a 7 day gain of 2.7%, and a month return of an 8.1% decline as of the latest close. See our latest analysis for United Community Banks. At around $30.93 per share, the recent 8.1% 30 day share price decline contrasts with a 14.9% 1 year total shareholder return. This suggests shorter term caution, while longer term investors have...

Investors may be wondering whether Materion, at around US$141 a share, still offers value or if most of the potential upside has already been priced in. The stock has moved sharply, with a 7.1% gain over the last week, a 12.5% decline over the last month, and returns of 10.0% year to date and 70.4% over the past year. These swings have kept the stock on many investors' watchlists, as price action alone does not explain what is driving sentiment. Recent coverage has focused on how the...

In March 2026, Kingsoft Cloud Holdings reported record fourth-quarter and full-year 2025 revenue of CNY 2,761.39 million and CNY 9,558.62 million respectively, alongside narrower net losses, board and committee leadership changes, and proposed amendments to its articles of association to enable virtual shareholder meetings and align with Hong Kong Listing Rules. A key highlight was very large AI business gross billing growth, with AI-related services contributing nearly half of public cloud...

If you are wondering whether Plains GP Holdings at around US$24.46 still offers value or if most of the opportunity is already priced in, the starting point is to look closely at what the market is paying for its fundamentals. The stock has delivered returns of 3.3% over the past week, 10.2% over the last month, 26.0% year to date and 23.4% over the past year, with a very large 3 year gain and a 272.0% return over 5 years that may shape current expectations and risk views. Recent headlines...

Pentair (NYSE:PNR) announced the retirement of long-serving Chair David A. Jones after more than two decades on the Board and eight years as Chair. T. Michael Glenn, an independent director with extensive board experience, has been appointed as the new Chair. The transition marks a planned change in board leadership and governance oversight at Pentair. Pentair focuses on water treatment and fluid management solutions, an area that sits at the intersection of infrastructure, sustainability...

Graco recently reported a past quarter with revenues up 8.1% year on year and earnings exceeding analysts’ EBITDA expectations, reflecting solid near‑term execution. However, flat sales over the last two years, declining earnings per share, and shrinking returns on capital have raised concerns about longer‑term growth and profitability. We’ll now explore how these signs of muted long‑term growth, despite a recent earnings beat, may influence Graco’s broader investment narrative. Outshine the...

Why Donaldson Company (DCI) is on investors’ radar today Recent performance in Donaldson Company (DCI) shares, including a roughly 20% decline over the past month and an 8% decline over the past 3 months, has drawn fresh investor attention. With the stock last closing at US$83.87 and a market value of about US$9.8b, investors are weighing how the filtration specialist’s current valuation compares with its business mix and profitability. See our latest analysis for Donaldson Company. The...

Earlier this week, a Los Angeles jury ruled that Alphabet’s Google and Meta designed YouTube and Instagram in ways that contributed to a young woman’s social media addiction and mental health harms, awarding a combined US$6.00 million in compensatory and punitive damages and finding both companies failed to adequately warn users about these risks. This verdict targets the core design of engagement-driving features rather than user content, potentially reshaping legal protections under...

Earlier in 2026, Zimmer Biomet was honored with three Healthcare Asia Medtech Awards for its iodine-treated hip implants, WalkAI recovery platform, and surgeon engagement initiatives, underscoring its focus on orthopedic and digital health innovation. The recognition for WalkAI, which applies artificial intelligence to monitor knee replacement recovery and enable earlier clinical intervention, highlights how Zimmer Biomet is pairing traditional implants with data-driven tools to support...

AbbVie (NYSE:ABBV) is presenting new clinical research across its dermatology portfolio at the 2026 American Academy of Dermatology Annual Meeting. The company is showcasing data on treatment outcomes for immune mediated skin diseases, including late breaking Phase 3 results in vitiligo and alopecia areata. The presentations feature durable long term outcomes, quality of life measures, and investigational results for new indications. For investors, this update highlights how AbbVie is...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

On March 17, 2026, Universal Technical Institute Director George W. Brochick disclosed an indirect sale of 5,000 shares in an SEC Form 4 filing, while the company continued to benefit from solid operating performance and a new multi-year equipment agreement with Fuji Spray Auto for student training. An interesting angle is that Brochick’s sale appears routine given his remaining holdings, keeping investor attention on Universal Technical Institute’s operational progress and its expanded...